3 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Chilton Trust Royal Palm Private Equity Fund II | August 2026 | Indefinite | $32M | 20 |
| Chilton Trust Royal Palm Growth Fund | November 2025 | Indefinite | $13M | 39 |
| Chilton Trust Royal Palm Absolute Return Fund | July 2025 | Indefinite | $21M | 36 |
| Chilton Private Equity Fund | March 2024 | Indefinite | $33M | 40 |
| Chilton - Whale Rock Hybrid Access FundFiled to raise in 2021, with no closing reported yet. |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
32 partners are named across this firm’s filings, 3 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| James HendersonNot on the current fund | Selective | None listed | 5 |
Classified sectors of Chilton’s own portfolio companies, based on 3 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Chilton’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Chilton Investment Partners | 31 | ACTIV Surgical, ALEXCO RESOURCE, ASSUREDPARTNERS, AYTU BIOSCIENCE, Better Place Wellness, Brand Engagement Network, Compass Gold, Curisium, Entrada Therapeutics, Far UV Technologies, Futurism Markets, Futurism, Gargoyle Enterprises, GRAPH BLOCKCHAIN, Knetik, LegWorks, Lumerit Education, mindzie, NANOPHASE TECHNOLOGIES, No Safe Til Brooklyn Ltd Liability, NYC Green Transportation Group, PARKER MARITIME TECHNOLOGIES, RAAPID, S4 Capital plc, SeaStar Medical Holding, Silver Heritage Group, Splife, USC, VantageCrypto, Workhorse Group, World Surveillance Group |
| Absolute Return | 1 | ACTIV Surgical |
| Balcera Fund Ltd |
| 2021 |
| Indefinite |
| $0 |
| 0 |
| Chilton Advantage Fund | August 2016 | Indefinite | $18M | 5 |
| Chilton Trust Royal Palm Equity Fund | 2016 | Indefinite | $84M | 80 |
| Chilton Mid Cap Core Equities | February 2013 | Indefinite | $15M | 6 |
| Chilton Global Natural Resources Long Opportunities (BVI) | 2013 | Indefinite | $250M | 17 |
| Chilton Global Natural Resources Long Opportunities | 2013 | Indefinite | $33M | 6 |
| Chilton Strategic Equities | March 2012 | Indefinite | $15M | 15 |
| Chilton Dividend Shares | October 2011 | Indefinite | $32M | 21 |
| Chilton Hedged U.S. Equities | 2011 | Indefinite | $44M | 51 |
| Chilton Core Equities | 2010 | Indefinite | $16M | 10 |
| Chilton Global Balanced | 2010 | Indefinite | $9.5M | 8 |
| Chilton Global Credit Opportunities | August 2006 | Indefinite | $43M | 17 |
| Chilton Global Natural Resources International (BVI) | 2006 | Indefinite | $3.5B | 401 |
| Chilton Global Natural Resources Partners | August 2005 | Indefinite | $1.7B | 610 |
| CHILTON STRATEGIC VALUE INTERNATIONAL II (BVI) | May 2005 | Indefinite | $145M | 19 |
| Chilton Strategic Value Partners | October 2004 | Indefinite | $378M | 107 |
| Chilton Small Cap & Mid Cap International (BVI) | 2002 | Indefinite | $1.2B | 214 |
| Chilton Small Cap & Mid Cap Partners | 2002 | Indefinite | $895M | 144 |
| Chilton Small Cap & Mid Cap International | 2002 | Indefinite | $2.2B | 3 |
| CHILTON EUROPEAN INTERNATIONAL (BVI) | March 1999 | Indefinite | $999M | 203 |
| Chilton QP European Partners | March 1999 | Indefinite | $330M | 141 |
| Chilton Opportunity Trust | October 1994 | Indefinite | $209M | 254 |
| Chilton International | December 1993 | Indefinite | $3.3B | 3 |
| Chilton International (BVI) | December 1993 | Indefinite | $3.3B | 511 |
| Chilton Investment Partners | July 1992 | Indefinite | $1.1B | 165 |
| 2 |
| David GreenNot on the current fund | Slowing | None listed | 9 | 1 |
| Michael ClarkNot on the current fund | Slowing | None listed | 12 | 1 |
| Alison SchachterNot on the current fund | Quiet | None listed | 0 | 0 |
| Andrew BurrNot on the current fund | Quiet | None listed | 0 | 0 |
| Bradley AdamsNot on the current fund | Quiet | None listed | 2 | 0 |
| Charles AbrechtNot on the current fund | Quiet | None listed | 0 | 0 |
| Colleen FergusonNot on the current fund | Quiet | None listed | 0 | 0 |
| Dale ThompsonNot on the current fund | Quiet | None listed | 0 | 0 |
| Daniel SzemisNot on the current fund | Quiet | None listed | 0 | 0 |
| Garrison LickleNot on the current fund | Quiet | None listed | 0 | 0 |
| James BosekNot on the current fund | Quiet | None listed | 0 | 0 |
| James SteinthalNot on the current fund | Quiet | None listed | 0 | 0 |
| Jenifer ParkerNot on the current fund | Quiet | None listed | 1 | 0 |
| Jennifer FosterNot on the current fund | Quiet | None listed | 0 | 0 |
| Jerry GoerschNot on the current fund | Quiet | None listed | 0 | 0 |
| Jonathan WainwrightNot on the current fund | Quiet | None listed | 0 | 0 |
| Joseph EggletonNot on the current fund | Quiet | None listed | 0 | 0 |
| Juergen GoerschNot on the current fund | Quiet | None listed | 0 | 0 |
| Julie JackNot on the current fund | Quiet | None listed | 0 | 0 |
| Kenneth ChiangNot on the current fund | Quiet | None listed | 0 | 0 |
| Leigh GoehringNot on the current fund | Quiet | None listed | 0 | 0 |
| Lisa CzachorNot on the current fund | Quiet | None listed | 0 | 0 |
| Louisa Ives | Quiet | None listed | 0 | 0 |
| Patricia MallonNot on the current fund | Quiet | None listed | 0 | 0 |
| Peter Kim | Quiet | Biotech & pharma, Digital health | 5 | 0 |
| Porter GossNot on the current fund | Quiet | None listed | 0 | 0 |
| Richard Chilton | Quiet | None listed | 0 | 0 |
| Robert WilliamsonNot on the current fund | Quiet | Biotech & pharma | 9 | 0 |
| Steven McPhersonNot on the current fund | Quiet | None listed | 0 | 0 |
| Timothy HoranNot on the current fund | Quiet | None listed | 1 | 0 |
| William BoardmanNot on the current fund | Quiet | None listed | 0 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
| 1 |
| ACTIV Surgical |
| Bridge Street | 1 | Perspective Therapeutics |
| Buckeye Fund Ltd | 1 | ACTIV Surgical |
| Cadence Alternative Investments | 1 | ACTIV Surgical |
| Cascade Fund Ltd | 1 | ACTIV Surgical |
| Cedar Investments Ltd | 1 | ACTIV Surgical |
| Charles2 Fund Ltd | 1 | ACTIV Surgical |
| Chilton Dividend Shares | 1 | TouchCare Holdings |
| Chilton Strategic Equities | 1 | TouchCare Holdings |
| Chilton Trust Royal Palm | 1 | TouchCare Holdings |
| Clear Box Investments Ltd | 1 | ACTIV Surgical |
| Corktown Fund Ltd | 1 | ACTIV Surgical |
| Cota Capital Institutional Partners | 1 | ACTIV Surgical |
A shared board seat: a company where filings name a Chilton partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.
